DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Healthcare
Updated 2y ago
BIOS logo

Bioservo Technologies AB (publ)OM:BIOS Stock Report

Market Cap SEK 1.4m
Updated 2y ago
Share Price
n/a
1Y-99.2%
7D-14.9%
1D0%
Portfolio Value
​
View

Bioservo Technologies AB (publ)

OM:BIOS Stock Report

Market Cap: SEK 1.4m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bioservo Technologies (BIOS) Stock Overview

Develops and sells wearable muscle strengthening systems worldwide. More details

BIOS fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Trading at 99.4% below our estimate of its fair value

Revenue is forecast to grow 69.31% per year

Trading at good value compared to peers and industry

Risk Analysis

Earnings have declined by 15.8% per year over past 5 years

Does not have a meaningful market cap (SEK1M)

Shareholders have been substantially diluted in the past year

Highly volatile share price over the past 3 months

+ 2 more risks

BIOS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW441,864 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
441,864 investors already sharing narratives
SEK
Current Price
SEK 0.01698.7% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-86m165m2016201920222025202620282031Revenue SEK 165.0mEarnings SEK 22.4m
Advanced
View all narratives

Bioservo Technologies AB (publ) Competitors

S2Medical

Symbol: OM:S2M
Market cap: SEK 5.1m

Bio Vitos Pharma

Symbol: OM:BIOVIT
Market cap: SEK 4.7m

Invent Medic Sweden

Symbol: NGM:IMS
Market cap: SEK 32.9m

Bio-Works Technologies

Symbol: NGM:BIOWKS
Market cap: SEK 326.0m

Price History & Performance

Summary of share price highs, lows and changes for Bioservo Technologies
Historical stock prices
Current Share PriceSEK 0.016
52 Week HighSEK 2.39
52 Week LowSEK 0.011
Beta0.80
1 Month Change-33.33%
3 Month Change-96.30%
1 Year Change-99.15%
3 Year Change-99.90%
5 Year Change-99.83%
Change since IPO-99.92%

Recent News & Updates

Recent updates

Analysis Article • Sep 01

Is Bioservo Technologies (STO:BIOS) In A Good Position To Deliver On Growth Plans?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Analysis Article • Apr 11

Bioservo Technologies (STO:BIOS) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysis Article • Dec 27

We're Not Very Worried About Bioservo Technologies' (STO:BIOS) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Shareholder Returns

BIOSSE Medical EquipmentSE Market
7D-14.9%-2.3%-1.4%
1Y-99.2%-1.1%12.1%

Return vs Industry: BIOS underperformed the Swedish Medical Equipment industry which returned -2.2% over the past year.

Return vs Market: BIOS underperformed the Swedish Market which returned 1.5% over the past year.

Price Volatility

Is BIOS's price volatile compared to industry and market?
BIOS volatility
BIOS Average Weekly Movement31.2%
Medical Equipment Industry Average Movement6.3%
Market Average Movement5.2%
10% most volatile stocks in SE Market10.6%
10% least volatile stocks in SE Market2.9%

Stable Share Price: BIOS's share price has been volatile over the past 3 months.

Volatility Over Time: BIOS's weekly volatility has increased from 19% to 31% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200320Petter Backgrenwww.bioservo.com

Bioservo Technologies AB (publ) develops and sells wearable muscle strengthening systems worldwide. The company offers Ironhand, a robotic grip that strengthens gloves; and Carbonhand, a revolutionary assistive device for people with impaired hand function. Its products have applications in foundry, logistics, warehousing, and construction sectors, as well as used in pre-assembly and assembly tasks.

Bioservo Technologies AB (publ) Fundamentals Summary

How do Bioservo Technologies's earnings and revenue compare to its market cap?
BIOS fundamental statistics
Market capSEK 1.36m
Earnings (TTM)-SEK 46.93m
Revenue (TTM)SEK 11.86m
0.1x
P/S Ratio
0.0x
P/E Ratio

Is BIOS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOS income statement (TTM)
RevenueSEK 11.86m
Cost of RevenueSEK 10.28m
Gross ProfitSEK 1.58m
Other ExpensesSEK 48.51m
Earnings-SEK 46.93m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Feb 20, 2024

Earnings per share (EPS)-0.55
Gross Margin13.30%
Net Profit Margin-395.68%
Debt/Equity Ratio0%

How did BIOS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/12 03:30
End of Day Share Price 2024/01/12 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bioservo Technologies AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mats HyttingeCarlsquare AB
Mats HyttingeRedeye

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide